← Leaderboards
Elizabeth Anne Hibler
Northwestern University At Chicago
$781,788
Attributed
$781,788
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $156.4K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$781,788 · 1
By mechanism
K01$781,788 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Yadav Sapkota$3,246,319
- Christina Dyar$3,358,426
- John Andrew Kalapurakal$3,554,577
- Francesca E. Duncan$6,656,849
- Takeshi Kurita$5,224,195
Others in their field
Other Emerging Leaders on “Career Development”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Prasant Mohapatra · University Of California At Davis$41,945,816
- Gary Kobinger · University Of Texas Med Br Galveston$34,500,000
- Eric C Palm · Florida State University$31,951,397
- Ross D McDonald · Florida State University$26,502,247
- Michael W Rabin · Florida State University$26,502,247
Research focus
Career DevelopmentCause Of DeathAgedAffectAnimalsCase ControlBreast Cancer DiagnosisBreast Cancer PatientBioinformaticsBreast Cancer SurvivorBreast Cancer TherapyBreast Cancer TreatmentCancer DiagnosisCancer EpidemiologyCancer PatientCancer SurvivorCardiacCardiac MyocytesBreast Cancer SurvivalCardiotoxicityCardiovascular DiseasesCardiovascular Disorder RiskCareerChemotherapy
Grant awards (5)
Predicting risk of cardiotoxicity among young and emerging adult breast cancer patients from treatment to survivorship$156,372
K01 · FY2024 · HL · contact PI
Predicting risk of cardiotoxicity among young and emerging adult breast cancer patients from treatment to survivorship$156,372
K01 · FY2023 · HL · contact PI
Predicting risk of cardiotoxicity among young and emerging adult breast cancer patients from treatment to survivorship$156,372
K01 · FY2022 · HL · contact PI
Predicting risk of cardiotoxicity among young and emerging adult breast cancer patients from treatment to survivorship$156,336
K01 · FY2021 · HL · contact PI
Predicting risk of cardiotoxicity among young and emerging adult breast cancer patients from treatment to survivorship$156,336
K01 · FY2020 · HL · contact PI